The UK government has commissioned an updated harms assessment of ketamine, as concerns grow over its rising misuse, particularly among young people. A stark 231% increase in ketamine use among 16 to 24-year-olds since 2013 has prompted action. The drug, currently classified as Class B under the Misuse of Drugs Act 1971, is under review, with experts set to determine if it should be reclassified as a Class A substance due to its detrimental effects.

Health reports highlight alarming risks associated with ketamine misuse, including severe addictiveness and irreversible bladder damage, which are often underestimated. Nearly 269,000 individuals aged 16-59 reported using ketamine in the year ending March 2024. This trend has raised significant public health concerns, sparking the government’s latest request for advice from the Advisory Council on the Misuse of Drugs (ACMD).

The move reflects the urgent need to address rising drug misuse in society, and experts are expected to provide recommendations on mitigating these harms. The assessment will form part of a broader focus on prioritising stricter controls to safeguard public health and the well-being of vulnerable populations.

Source: GOV.UK